What options are on the food-tech menu for achieving long-term protein security? Cell culture, plants, microorganisms, algae, and fungi may all have roles to play. But from a sustainability and resilience perspective, is there a clear winner?
Brave New Meat podcast host Doug Grant talks with Michael Aucoin, CEO of alternative protein investment firm Eat Beyond Global Holdings. As a publicly traded stock on the Canadian Securities Exchange, Eat Beyond (CSE: EATS) is currently one of the only options available offering retail investors early exposure to emerging alt protein startups and technologies.
Although antibiotics are generally thought of in the context of treating infections within our healthcare systems, that’s not where most are actually used. Globally, around 73% of all antibiotics are used in animals grown for food.